Skip to content
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
Donate
HR Login
MSF SA Login
›
Category: MSF in news
Hearing on Gilead's patent for hepatitis C drug, sofosbuvir, begins at patent office
Read More
"Doctors Without Borders blasts $1700 price tag of Otsuka TB drug"
Read More
MSF expresses concern over high price of new TB drug, delamanid of Otsuka Pharma
Read More
Activists raise concern over new life-saving TB drug cost
Read More
Doctors Without Borders blasts $1700 price tag of Otsuka TB drug
Read More
Hearing on Gilead's patent for hepatitis C drug, sofosbuvir, begins at patent office
Read More
Patient groups raise concern over affordability of new TB drug
Read More
Developing Countries Hit with High Price Tag for Critical New TB Drug
Read More
MSF slams 'ridiculously high price' of Otsuka's TB drug delamanid
Read More
Air strikes destroyed hospital in Syria, killed at least seven: MSF
Read More